TY - JOUR
T1 - Antibiotic resistance
T2 - Turning evolutionary principles into clinical reality
AU - Andersson, Dan I.
AU - Balaban, Nathalie Q.
AU - Baquero, Fernando
AU - Courvalin, Patrice
AU - Glaser, Philippe
AU - Gophna, Uri
AU - Kishony, Roy
AU - Molin, Søren
AU - Tønjum, Tone
N1 - Publisher Copyright:
© FEMS 2020. All rights reserved. For permissions, please e-mail: [email protected]
PY - 2020/3/1
Y1 - 2020/3/1
N2 - Antibiotic resistance is one of the major challenges facing modern medicine worldwide. The past few decades have witnessed rapid progress in our understanding of the multiple factors that affect the emergence and spread of antibiotic resistance at the population level and the level of the individual patient. However, the process of translating this progress into health policy and clinical practice has been slow. Here, we attempt to consolidate current knowledge about the evolution and ecology of antibiotic resistance into a roadmap for future research as well as clinical and environmental control of antibiotic resistance. At the population level, we examine emergence, transmission and dissemination of antibiotic resistance, and at the patient level, we examine adaptation involving bacterial physiology and host resilience. Finally, we describe new approaches and technologies for improving diagnosis and treatment and minimizing the spread of resistance.
AB - Antibiotic resistance is one of the major challenges facing modern medicine worldwide. The past few decades have witnessed rapid progress in our understanding of the multiple factors that affect the emergence and spread of antibiotic resistance at the population level and the level of the individual patient. However, the process of translating this progress into health policy and clinical practice has been slow. Here, we attempt to consolidate current knowledge about the evolution and ecology of antibiotic resistance into a roadmap for future research as well as clinical and environmental control of antibiotic resistance. At the population level, we examine emergence, transmission and dissemination of antibiotic resistance, and at the patient level, we examine adaptation involving bacterial physiology and host resilience. Finally, we describe new approaches and technologies for improving diagnosis and treatment and minimizing the spread of resistance.
KW - Antibiotic resistance
KW - Evolution
KW - New therapy
KW - Prevention
KW - Rapid diagnostics
KW - Transmission
UR - http://www.scopus.com/inward/record.url?scp=85081726907&partnerID=8YFLogxK
U2 - 10.1093/FEMSRE/FUAA001
DO - 10.1093/FEMSRE/FUAA001
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 31981358
AN - SCOPUS:85081726907
SN - 0168-6445
VL - 44
SP - 171
EP - 188
JO - FEMS Microbiology Reviews
JF - FEMS Microbiology Reviews
IS - 2
M1 - FUAA001
ER -